Generation of three hiPSC clones from a Parkinson's disease patient with a heterozygous variant of VPS35 p.D620N

Stem Cell Res. 2022 Apr:60:102739. doi: 10.1016/j.scr.2022.102739. Epub 2022 Feb 28.

Abstract

Approximately 10% of Parkinson's disease cases are familial and more than 20 disease-related genes have been identified. The VPS35 gene causes a rare type of Parkinson's disease called PARK17, which is inherited in an autosomal dominant manner. The VPS35 gene encodes a retromer complex, but the pathogenic mechanism involved in PARK17 is unknown. Here, we established three isogenic induced pluripotent stem cell (iPSC) lines from a patient harboring a heterozygous VPS35 c.1858G > A (p.D620N) variant. The derived iPSCs showed pluripotency, the capacity to differentiate into three germ layers, and normal karyotypes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Clone Cells / metabolism
  • Heterozygote
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Mutation
  • Parkinson Disease* / genetics
  • Parkinson Disease* / metabolism
  • Vesicular Transport Proteins / genetics

Substances

  • VPS35 protein, human
  • Vesicular Transport Proteins